Daily medication use in nursing home residents with advanced dementia
- PMID: 20406320
- PMCID: PMC2910133
- DOI: 10.1111/j.1532-5415.2010.02819.x
Daily medication use in nursing home residents with advanced dementia
Abstract
Objectives: To describe the pattern and factors associated with daily medication use in nursing home (NH) residents with advanced dementia.
Design: Prospective cohort study.
Setting: Twenty-two Boston-area NHs.
Participants: NH residents with advanced dementia (N=323).
Measurements: Data from residents' records were used to determine the number or daily medications, specific drugs prescribed, and use of drugs deemed "never appropriate" in patients with advanced dementia. Resident characteristics associated with the use of more daily medications and drugs deemed inappropriate were examined.
Results: Residents were prescribed a mean of 5.9 +/- 3.0 daily medications, and 37.5% received at least one medication considered "never appropriate" in advanced dementia. Acetylcholinesterase inhibitors (15.8%) and lipid-lowering agents (12.1%) were the most common inappropriate drugs. Twenty-eight percent of residents took antipsychotics daily. Modest reductions in most daily medications occurred only during the last week of life. Factors independently associated with taking more daily medications included older age, male sex, non-white race, dementia not due to Alzheimer's disease, better cognition, cardiovascular disease, acute illness, and hospice referral. Factors independently associated with greater likelihood of taking inappropriate medications included being male, shorter NH stay, better functional status, and diabetes mellitus, whereas a do-not-hospitalize order was associated with a lower likelihood.
Conclusion: Questionably beneficial medications are common in advanced dementia, even as death approaches. Several characteristics can help identify residents at risk for greater medication burden. Medication use in advanced dementia should be tailored to the goals of care.
Figures
Similar articles
-
Potentially Inappropriate Prescribing in Australian Nursing Home Residents with Advanced Dementia: A Substudy of the IDEAL Study.J Palliat Med. 2018 Oct;21(10):1472-1479. doi: 10.1089/jpm.2018.0070. Epub 2018 Aug 14. J Palliat Med. 2018. PMID: 30106321 Clinical Trial.
-
Use of medications of questionable benefit in advanced dementia.JAMA Intern Med. 2014 Nov;174(11):1763-71. doi: 10.1001/jamainternmed.2014.4103. JAMA Intern Med. 2014. PMID: 25201279 Free PMC article.
-
Development and application of medication appropriateness indicators for persons with advanced dementia: a feasibility study.Drugs Aging. 2015 Jan;32(1):67-77. doi: 10.1007/s40266-014-0226-9. Drugs Aging. 2015. PMID: 25480124
-
Prevalence of psychotropic polypharmacy in nursing home residents with dementia: a meta-analysis.Int Psychogeriatr. 2021 Oct;33(10):1083-1098. doi: 10.1017/S1041610220004032. Epub 2021 Jan 7. Int Psychogeriatr. 2021. PMID: 33407955 Review.
-
Medication Use Among Nursing Home Residents With Severe Dementia: Identifying Categories of Appropriateness and Elements of a Successful Intervention.J Am Med Dir Assoc. 2015 Jul 1;16(7):629.e1-17. doi: 10.1016/j.jamda.2015.04.002. Epub 2015 May 13. J Am Med Dir Assoc. 2015. PMID: 25979776 Review.
Cited by
-
Prevalence of potentially inappropriate medications according to STOPP-Frail criteria in nursing home residents, the SHELTER study.BMC Geriatr. 2024 Oct 26;24(1):882. doi: 10.1186/s12877-024-05450-y. BMC Geriatr. 2024. PMID: 39462318 Free PMC article.
-
A Novel Protocol for the Early Detection of COVID-19 at a Skilled Nursing Facility.Gerontol Geriatr Med. 2024 Sep 3;10:23337214241279531. doi: 10.1177/23337214241279531. eCollection 2024 Jan-Dec. Gerontol Geriatr Med. 2024. PMID: 39234017 Free PMC article.
-
A need to integrate pharmacological management for multimorbidity into dementia guidelines in Australia.Front Public Health. 2024 Jul 23;12:1425195. doi: 10.3389/fpubh.2024.1425195. eCollection 2024. Front Public Health. 2024. PMID: 39109156 Free PMC article. Review.
-
Global prevalence of polypharmacy and potentially inappropriate medication in older patients with dementia: a systematic review and meta-analysis.Front Pharmacol. 2023 Aug 24;14:1221069. doi: 10.3389/fphar.2023.1221069. eCollection 2023. Front Pharmacol. 2023. PMID: 37693899 Free PMC article.
-
The OptimaMed intervention to reduce medication burden in nursing home residents with severe dementia: results from a pragmatic, controlled study.BMC Geriatr. 2023 Aug 28;23(1):520. doi: 10.1186/s12877-023-04222-4. BMC Geriatr. 2023. PMID: 37641020 Free PMC article. Clinical Trial.
References
-
- Magaziner J, German P, Zimmerman SI, et al. Epidemiology of Dementia in Nursing Homes Research Group The prevalence of dementia in a statewide sample of new nursing home admissions aged 65 and older: Diagnosis by expert panel. Gerontologist. 2000;40:663–672. - PubMed
-
- Gruber-Baldini AL, Stuart B, Zuckerman IH, et al. Treatment of dementia in community-dwelling and institutionalized medicare beneficiaries. J Am Geriatr Soc. 2007;55:1508–1516. - PubMed
-
- Bynum JP, Rabins PV, Weller W, et al. The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc. 2004;52:187–194. - PubMed
-
- Doshi JA, Shaffer T, Briesacher BA. National estimates of medication use in nursing homes: findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey. J Am Geriatr Soc. 2005;53:438–443. - PubMed
-
- Beers MH, Ouslander JG, Fingold SF, et al. Inappropriate medication prescribing in skilled-nursing facilities. Ann Intern Med. 1992;117:684–689. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG024091-01/AG/NIA NIH HHS/United States
- R01 AG024091-01S1/AG/NIA NIH HHS/United States
- K08 AG021527-05/AG/NIA NIH HHS/United States
- R01 AG024091/AG/NIA NIH HHS/United States
- R01 AG024091-02/AG/NIA NIH HHS/United States
- K08AG021527/AG/NIA NIH HHS/United States
- R01 AG024091-04/AG/NIA NIH HHS/United States
- K24AG033640/AG/NIA NIH HHS/United States
- R01 AG024091-03/AG/NIA NIH HHS/United States
- K08 AG021527-06/AG/NIA NIH HHS/United States
- K08 AG021527/AG/NIA NIH HHS/United States
- K24 AG033640/AG/NIA NIH HHS/United States
- R01 AG024091-05/AG/NIA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
